MetaCap

BlossomHill Therapeutics Insider Trades

NASDAQ: BLSMHealth CareBiotechnology: Pharmaceutical PreparationsUSD

17.48+0.60 (+3.55%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
7 · $25.18M
Sales
0 · $0
Shares bought / sold
1.57M / 0
Net activity
Net buying $25.2 million

BlossomHill Therapeutics insider activity

Over the last 12 months, BlossomHill Therapeutics insiders reported 21 transactions on SEC Form 4: 7 open-market purchases and 0 sales. Insiders bought $25.2 million and sold $0 worth of stock, for net insider buying of $25.2 million. The most recent filing shows GORDON CARL L (Director) reporting a transaction in 1,039,996 shares on Aug 10, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put BLSM's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

BLSM insider transactions

BlossomHill Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Aug 10, 2026Cui Jingrong JeanPresident and CEOConversion124,779—Form 4
Aug 10, 2026Cui Jingrong JeanPresident and CEOConversion113,435—Form 4
Aug 10, 2026Cui Jingrong JeanPresident and CEOConversion1,600,682—Form 4
Aug 10, 2026Liptak Vincent PaulGeneral CounselConversion22,687—Form 4
Aug 10, 2026Liptak Vincent PaulGeneral CounselBuy2,200$35.20KForm 4
Aug 10, 2026Chen Bihua & Cormorant Asset Management, LP & Cormorant Global Healthcare Master Fund, LP & Cormorant Private Healthcare Fund III LP & Cormorant Private Healthcare Fund V LP & Cormorant Private Healthcare Fund VI, LPDirectorBuy312,500$5.00MForm 4
Aug 10, 2026Chen Bihua & Cormorant Asset Management, LP & Cormorant Global Healthcare Master Fund, LP & Cormorant Private Healthcare Fund III LP & Cormorant Private Healthcare Fund V LP & Cormorant Private Healthcare Fund VI, LPDirectorConversion1,701,541—Form 4
Aug 10, 2026Chen Bihua & Cormorant Asset Management, LP & Cormorant Global Healthcare Master Fund, LP & Cormorant Private Healthcare Fund III LP & Cormorant Private Healthcare Fund V LP & Cormorant Private Healthcare Fund VI, LPDirectorConversion1,599,993—Form 4
Aug 10, 2026Li YishanExecutive ChairmanConversion124,779—Form 4
Aug 10, 2026Li YishanExecutive ChairmanConversion113,435—Form 4
Aug 10, 2026Li YishanExecutive ChairmanConversion1,600,682—Form 4
Aug 10, 2026Keyes Jason AChief Financial OfficerBuy700$11.20KForm 4
Aug 10, 2026Agrawal SundeepDirectorConversion578,524—Form 4
Aug 10, 2026Schmid John P.DirectorBuy6,000$96.00KForm 4
Aug 10, 2026ORBIMED ADVISORS LLC & OrbiMed Capital GP VIII LLCDirectorBuy625,000$10.00MForm 4
Aug 10, 2026ORBIMED ADVISORS LLC & OrbiMed Capital GP VIII LLCDirectorConversion1,049,283—Form 4
Aug 10, 2026ORBIMED ADVISORS LLC & OrbiMed Capital GP VIII LLCDirectorConversion1,039,996—Form 4
Aug 10, 2026GORDON CARL LDirectorBuy625,000$10.00MForm 4
Aug 10, 2026GORDON CARL LDirectorConversion1,049,283—Form 4
Aug 10, 2026GORDON CARL LDirectorConversion1,039,996—Form 4
Aug 7, 2026Liptak Vincent PaulGeneral CounselBuy2,500$39.50KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related